Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| level 7 aggressive prostate cancer |
|
National Prostate Cancer Coalition (NPCC) The rate of increase in your PSA level (PSA Velocity) may tell you more than your PSA level itself. . Smaller Prostate Size, More Aggressive Cancer Prostate Cancer: High Pretreatment PSA Velocity Predicts Worse Outcome The most significant single predictor of aggressive prostate cancer is an score greater than 7, a PSA level of 10 ng/ml or an advanced disease category. PCAW - Prostate Cancer Awareness Week - Personal Perspectives on Check with your doctor ASAP to see what your cholesterol level is at this time. of being diagnosed with more aggressive prostate cancer (Gleason 7-10) Newer Approach Urged In Screening For Aggressive Prostate Cancer Findings of a Hopkins study of PSAV, in this month's Journal of the National Cancer Institute, may add a new level of predictive accuracy to prostate cancer The Journal of Urology : Association Between the Association Between the Dihydrotestosterone Level in the Prostate and Prostate Cancer Low dihydrotestosterone in cases of aggressive prostate cancer is The Journal of Urology : The Change in the Dihydrotestosterone Furthermore, the prostate with aggressive prostate cancer can produce indicate that a substantial level of DHT remains in the prostate after castration. Center News - 7/17/03 - Smoking & Prostate Cancer Risk PHS study links heavy, long-term cigarette exposure to aggressive prostate cancer, but shows that risks decline for those who quit Sunnybrook Health Sciences Centre News & Media TOOL CAN On the other hand, in the case of an older patient with a high PSA level, if the nomogram predicts a low chance of having aggressive prostate cancer, Does black men have more aggressive prostate cancer? from Does black men have more aggressive prostate cancer? from medicineworld.org, and 1.49 in black men and 1.35 in white men of Gleason score 7 tumors. ACS :: Rapid Rise in PSA May Predict Aggressive Prostate Cancer How quickly a man's PSA level has been rising before a diagnosis of prostate cancer may help doctors predict whether the cancer is more likely to kill him, Progress toward Identifying Aggressive Prostate Cancer operative PSA level of more than 10.0 ng per millili-. ter, and only 4 percent had a Gleason score tification of aggressive prostate cancer. Assessment Statistics and prognosis for prostate cancer A Gleason score of 2, 3 or 4 indicates a low grade prostate cancer that is likely to grow very slowly. A Gleason score of 5, 6 or 7 is an intermediate grade Prostate cancer - Wikipedia, the free encyclopedia The PSA test measures the blood level of prostate-specific antigen, . that may alert men if they have prostate cancer and how aggressive it will be. Prostate Cancer Case Studies - ProstateLine.com It is not surprising that prostate cancer patients, many of whom have erectile patients with an undetectable PSA level 7 years after surgery rarely Prostate Cancer and Race Aggressive treatment options include radiation therapy and radical early stage prostate cancer.7 For the one third of men with more aggressive prostate Prostate Cancer Research Institute - The Linkage Between Obesity Many hormones involved in obesity also play a role in the initiation and promotion of cancer both at a cellular, paracrine, and systemic level.7 In Defining Aggressive Prostate Cancer Using a 12-Gene Model A sample of localized prostate cancer (LPCa_442-GL_7) was naturally grouped with metastatic tumors. Although the overall Gleason score for this case was 7, Gene linked to aggressive prostate cancer: Science News Online A gene that is more active in prostate cancer tumors from may help explain why prostate cancer is both more common and more aggressive in African Americans. |
| level 7 aggressive prostate cancer |
|
prostate cancer bladder milking prostate video massager pantra prostate natural cure for prostate |